Active Ingredient(s): Doxapram
FDA Approved: * June 23, 1965
Pharm Company: * BAXTER HLTHCARE
Category: Respiratory Failure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Dopram Overview

Doxapram hydrochloride (marketed as Dopram, Stimulex or Respiram) is a respiratory stimulant. Administered intravenously, doxapram stimulates an increase in tidal volume, and respiratory rate. Contents 1 Mechanism of action 2 Appearance 3 Uses 4 Side effects 5 See also 6 References Mechanism of action A vial of doxapram Doxapram stimulates chemoreceptors in the carotid bodies of the carotid arteries, which in turn, stimulates the respiratory centre in the brain stem. Appearance D...

Read more Dopram Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Dopram Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 20mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dopram: (2 results)

Sorted by National Drug Code
  • 0641-6018 Dopram 20 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp.
  • 60977-144 Dopram 20 mg/ml Intravenous Injection by Baxter Healthcare Corporation

Other drugs which contain Doxapram or a similar ingredient: (1 result)